Mabpharm Limited (HKEX:2181) Filings
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026 | Nov 3, 2026 | Monthly return | HKEX |
| Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026 | Oct 6, 2026 | Monthly return | HKEX |
| 2026 Interim Report | Sep 21, 2026 | Interim report | HKEX |
| THIRD AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION | Jun 26, 2026 | Other filings | HKEX |
| VOLUNTARY ANNOUNCEMENT APPROVAL FROM THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION ON THE NEW DRUG APPLICATION (NDA) OF OUR PIPELINE PRODUCT, CMAB807X (DENOSUMAB INJECTION) | Jun 24, 2026 | Operations update | HKEX |